Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinoma
CONCLUSION: In patients undergoing surgical resection for locally advanced adenocarcinoma of the GOJ, OS and DFS did not differ significantly between patients who had neoadjuvant chemoradiation compared with chemotherapy.PMID:34476473 | DOI:10.1093/bjs/znab228
Source: The British Journal of Surgery - Category: Surgery Authors: E L Vos R A Carr M Hsu M Nakauchi T Nobel A Russo A Barbetta K S Tan L Tang D Ilson G Y Ku A J Wu Y Y Janjigian S S Yoon M S Bains D R Jones D Coit D Molena V E Strong Source Type: research
More News: Adenocarcinoma | Brain | Cancer | Cancer & Oncology | Chemotherapy | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Neurology | Neurosurgery | Surgery | UK Health